Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2402971
Max Phase: Preclinical
Molecular Formula: C67H101N27O22S2Se2
Molecular Weight: 1858.77
Molecule Type: Unknown
Associated Items:
ID: ALA2402971
Max Phase: Preclinical
Molecular Formula: C67H101N27O22S2Se2
Molecular Weight: 1858.77
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H](N)C(=O)NC1C[Se][Se]CC2NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)CN(C)C(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CSSC[C@@H](C(N)=O)NC2=O)NC(=O)[C@H](CC(N)=O)NC1=O
Standard InChI: InChI=1S/C67H101N27O22S2Se2/c1-29(68)52(103)92-46-26-119-120-27-47-64(115)90-44(51(70)102)24-117-118-25-45(91-58(109)39(16-48(69)98)85-63(46)114)62(113)88-42(22-96)61(112)89-43(23-97)65(116)94(3)20-49(99)81-37(14-31-18-78-34-9-5-4-8-33(31)34)56(107)80-30(2)53(104)82-35(10-6-12-76-66(71)72)54(105)86-40(17-50(100)101)59(110)84-38(15-32-19-75-28-79-32)57(108)87-41(21-95)60(111)83-36(55(106)93-47)11-7-13-77-67(73)74/h4-5,8-9,18-19,28-30,35-47,78,95-97H,6-7,10-17,20-27,68H2,1-3H3,(H2,69,98)(H2,70,102)(H,75,79)(H,80,107)(H,81,99)(H,82,104)(H,83,111)(H,84,110)(H,85,114)(H,86,105)(H,87,108)(H,88,113)(H,89,112)(H,90,115)(H,91,109)(H,92,103)(H,93,106)(H,100,101)(H4,71,72,76)(H4,73,74,77)/t29-,30-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46?,47?/m0/s1
Standard InChI Key: HVQZRKZYDQGZFA-CSEGTXKHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1858.77 | Molecular Weight (Monoisotopic): 1859.5386 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Walewska A, Han TS, Zhang MM, Yoshikami D, Bulaj G, Rolka K.. (2013) Expanding chemical diversity of conotoxins: peptoid-peptide chimeras of the sodium channel blocker μ-KIIIA and its selenopeptide analogues., 65 [PMID:23707919] [10.1016/j.ejmech.2013.04.041] |
Source(1):